Sebastian Bate

Manchester, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

Response to the Letter to the Editor Entitled "Re-examining the Causal Link Between Immunosuppression Delay and Kidney Outcomes in Autoimmune Membranous Nephropathy".

Response to the Letter to the Editor Entitled "Re-examining the Causal Link Between Immunosuppression Delay and Kidney Outcomes in Autoimmune Membranous Nephropathy".

Journal: Kidney international reports
Published: July 21, 2025

Kinetics of CD19+ B-cell depletion post-rituximab in membranous nephropathy.

Kinetics of CD19+ B-cell depletion post-rituximab in membranous nephropathy.

Journal: Clinical kidney journal
Published: May 12, 2025

Reduced treatment response to inhaled corticosteroids in current smokers with COPD, regardless of blood eosinophil count: insights from the FLAME trial.

Reduced treatment response to inhaled corticosteroids in current smokers with COPD, regardless of blood eosinophil count: insights from the FLAME trial.

Journal: Thorax
Published: May 11, 2025

Determinants of adult Ventriculoperitoneal Shunt failure: Insights from a large neurosurgical centre.

Determinants of adult Ventriculoperitoneal Shunt failure: Insights from a large neurosurgical centre.

Journal: Clinical neurology and neurosurgery
Published: April 29, 2025

Disproportionate increase in COPD exacerbation risk for 3 months after discontinuing LAMA or ICS: insights from the FLAME trial.

Disproportionate increase in COPD exacerbation risk for 3 months after discontinuing LAMA or ICS: insights from the FLAME trial.

Journal: Thorax
Published: March 07, 2025

Predictors of treatment REsponse to inhaled corticosteroids (ICS) in Chronic Obstructive pulmonary disease: randomised controlled trials individual participant Data re-Evaluation-protocol of the ICS-RECODE individual participant data meta-analysis.

Predictors of treatment REsponse to inhaled corticosteroids (ICS) in Chronic Obstructive pulmonary disease: randomised controlled trials individual participant Data re-Evaluation-protocol of the ICS-RECODE individual participant data meta-analysis.

Journal: BMJ open
Published: March 05, 2025

Impact of Time-To-Treatment on Outcomes in Autoimmune Membranous Nephropathy.

Impact of Time-To-Treatment on Outcomes in Autoimmune Membranous Nephropathy.

Journal: Kidney international reports
Published: September 02, 2024

Will the ANCA Kidney Risk Score Become the Gold Standard for Prognostication in ANCA-Associated GN?

Will the ANCA Kidney Risk Score Become the Gold Standard for Prognostication in ANCA-Associated GN?

Journal: Kidney360
Published: June 27, 2024

External Validation of Prognostic Models in Critical Care: A Cautionary Tale From COVID-19 Pneumonitis.

External Validation of Prognostic Models in Critical Care: A Cautionary Tale From COVID-19 Pneumonitis.

Journal: Critical care explorations
Published: March 29, 2024

Rethinking Blood Eosinophils for Assessing Inhaled Corticosteroids Response in COPD: A Post Hoc Analysis From the FLAME Trial.

Rethinking Blood Eosinophils for Assessing Inhaled Corticosteroids Response in COPD: A Post Hoc Analysis From the FLAME Trial.

Journal: Chest
Published: March 10, 2024

Treating Tobacco Dependency in National Health Service Workers in Greater Manchester: An Evaluation of a Bespoke Digital Service.

Treating Tobacco Dependency in National Health Service Workers in Greater Manchester: An Evaluation of a Bespoke Digital Service.

Journal: JTO clinical and research reports
Published: December 28, 2023

Ten-year trend analysis of breast cancer, oncoplastic, and reconstructive breast surgery in a single institution (2010-2019), what has not changed?

Ten-year trend analysis of breast cancer, oncoplastic, and reconstructive breast surgery in a single institution (2010-2019), what has not changed?

Journal: Breast cancer research and treatment
Published: December 10, 2023
Showing 1-12 of 22

Last Updated: 09/26/2026